enGene Holdings Inc. (ENGN)
(Delayed Data from NSDQ)
$7.19 USD
+0.33 (4.81%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $7.19 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Price, Consensus and EPS Surprise
ENGN 7.19 +0.33(4.81%)
Will ENGN be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for ENGN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Other News for ENGN
Analysts’ Opinions Are Mixed on These Real Estate Stocks: enGene Holdings (ENGN), CoStar Group (CSGP) and Umh (UMH)
Insider Buying: CEO Cooper Ronald Harold Wilfred Acquires Shares of enGene Holdings Inc (ENGN)
Buy Rating Affirmed on enGene Holdings Amidst Promising Efficacy Data and Strategic Protocol Amendments
Buy Rating Affirmed for enGene Holdings Amid Promising Phase 2 Results and Strategic Clinical Expansion
Buy Rating Justified: enGene Holdings’ Promising Future in NMIBC Therapy Despite Market Skepticism